Stratify Prostate™ is a national initiative to provide
no-cost tumor sequencing and new clinical trial options
to 10,000 men with metastatic prostate cancer, with the
goal of broadening access and accelerating drug approvals.
Conceived by leading physicians and researchers from UCSF Helen Diller Family Comprehensive Cancer Center and Strata Oncology, a precision oncology company.